Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
BackgroundEsophageal cancer (EC) is the seventh-most prevalent cancer worldwide and is a significant contributor to cancer-related mortality. Metabolic reprogramming in tumors frequently coincides with aberrant immune function alterations, and extensiv…